Related Experiment Video
Updated: Sep 11, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Integrating 7-day D-dimer exposure into deep vein thrombosis risk prediction after gastrointestinal surgery
Shuwei Weng1,2,3, Chen Ding3, Die Hu1,2
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
Deep vein thrombosis (DVT) is a serious complication following gastrointestinal surgery. While D-dimer is a widely used biomarker for thrombosis, its postoperative specificity is limited due to inflammatory interference. This study introduces a novel cumulative metric-7-day D-dimer exposure (7dDDE)-to quantify perioperative coagulation burden. We retrospectively analyzed 525 patients undergoing gastrointestinal surgery, performed propensity score matching, and constructed a multivariable logistic regression model incorporating 7dDDE and other clinical variables. Model performance was evaluated using ROC curves, decision curve analysis, calibration plots, SHAP values, and a nomogram. Additionally, a linear mixed-effects model assessed D-dimer trajectories over time. The results demonstrated that 7dDDE was independently associated with postoperative DVT and was the most influential predictor in the model. The model showed good discrimination and clinical utility. Longitudinal analysis further revealed significant differences in D-dimer dynamics between DVT and non-DVT groups, even after adjustment for confounders. These findings support the use of 7dDDE as a robust biomarker for thrombotic risk stratification and highlight the importance of integrating temporal biomarker patterns into perioperative DVT prediction.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management

